Barely Significant
← all excerpts

Bone-Targeted Agents and Metastasis Prevention.

Cancers (Basel) · 2022 · PMC9367604 · PMID 35892899

Europe PMCDOI
1
hedged sentence
0.0002
closest p · 0.0× alpha
0.0002
boldest claim

The sentences

highly significantp = 0.0002actually significant
This meta-analysis failed to show any benefits of adjuvant bisphosphonates in premenopausal women, but highly significant improvements in bone recurrence (RR = 0.72; 95% CI 0.60–0.86, 2 p = 0.0002) and breast cancer mortality (RR = 0.82; 95% CI 0.73–0.93, 2 p = 0.002) were seen in the 11,767 postmenopausal women included in the meta-analysis.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.